Stay updated on PLACARD Trial: CXD101 + Pembrolizumab in DLBCL
Sign up to get notified when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.

Latest updates to the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page
- ChecktodayChange DetectedThe web page has undergone significant changes, including the addition of new medical terms and disease classifications related to diffuse large B-cell lymphoma, while also removing several related terms and location details.SummaryDifference4%
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1.0%
- Check36 days agoChange DetectedThe web page has updated its version from v2.16.6 to v2.16.8 and added a section on HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to PLACARD Trial: CXD101 + Pembrolizumab in DLBCL
Enter your email address, and we'll notify you when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.